scPharmaceuticals, Inc. (SCPH): מקדם מחיר להכנסות

scPharmaceuticals Inc. (SCPH) cash flows are protected by patents for furosemide delivery systems and stringent FDA controls. The company's price-to-sales ratio clearly confirms this trend, where the value 6.00 represents the current metric. While high global growth potential is based on intellectual property, financial stability currently relies solely on the success of a single flagship product.
פילוחים אנליטיים של חברת scPharmaceuticals Inc. (SCPH)

For scPharmaceuticals Inc. (SCPH), which monetizes home treatment for heart failure via the Furoscix system, this indicator determines the market value of each unit of generated revenue. By analyzing the P/S multiple, an investor compares market capitalization with revenue from insurance reimbursements, allowing for an assessment of the premium paid for business scaling potential and the sustainability of the valuation amid the transition of patients from inpatient to home care.